Dr. Stefanie Greifeneder

Court Rulings on Pharmacy Marketing Remain Strict: OLG Frankfurt Prohibits Voucher Advertising

by Kathleen Munstermann-Senff, LL.M. (Medizinrecht) and Dr. Daniel Tietjen

Advising SENISCA on its partnership with L'Oréal

by Colin McCall and Charlie Adams

The Critical Medicines Act: A New Pillar of European Pharmaceutical Resilience

by Alina Krukover

China’s Rare Earth Export Controls: Implications for European Life Sciences Companies

by Dr. Amir-Said Ghassabeh

Life Sciences as a Security-Relevant Sector: Is Innovation at Risk under European and German FDI Control?

by Dr. Carolin Roßkothen, LL.M.

Corporate Venturing in Life Sciences: Making Partnerships Truly Strategic

Higher Regional Court of Frankfurt am Main on online referral of doctors for the prescription of medical cannabis

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Request for a preliminary ruling by the BGH to the CJEU on the scope of the duty of care of medical device distributors

by Dr. Daniel Tietjen and Daniel Dietrich

Appeal proceedings on the admissibility of granting Rx bonuses to a mail-order pharmacy based in the EU

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Federal Court of Justice (BGH): Placing medicinal products on the market within the meaning of Section 43 (1) of the German Medicines Act (AMG) when selling pharmacy-only medicines via the Amazon Marketplace

by Dr. Daniel Tietjen and Daniel Dietrich